Cargando…
Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
Autores principales: | Benesh, Gabrielle, Andriano, Tyler M., Cohen, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413661/ https://www.ncbi.nlm.nih.gov/pubmed/34504927 http://dx.doi.org/10.1016/j.jdcr.2021.08.005 |
Ejemplares similares
-
Refractory pemphigus vulgaris treated with rituximab and mycophenolate
mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014) -
Pemphigus vulgaris with refractory gingival ulcerations, successfully treated with rituximab—A case report
por: Dolenc‐Voljč, Mateja, et al.
Publicado: (2022) -
Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022) -
Cerebral toxoplasmosis after rituximab for pemphigus vulgaris
por: Lee, Erica B., et al.
Publicado: (2019) -
AZD-1222/rituximab: Pemphigus vulgaris and pemphigus vulgaris flare-up: 2 case reports
Publicado: (2022)